Results 11 to 20 of about 10,251 (261)

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure

open access: greenDrug Design, Development and Therapy, 2015
Maria Rosa Ballester,1,2 Eulàlia Roig,3,4 Ignasi Gich,1,2 Montse Puntes,1 Joaquín Delgadillo,2,5 Benjamín Santos,5 Rosa Maria Antonijoan1,21Drug Research Center (CIM), Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital ...
Ballester MR   +6 more
doaj   +1 more source

4-(3-Methylanilino)-N-[N-(1-methylethyl)carbamoyl]pyridinium-3-sulfonamidate (torasemide T–N): a low temperature redetermination [PDF]

open access: goldActa Crystallographica Section E, 2009
The structure [Danilovski et al. (2001). Croat. Chim. Acta 74, 103–120] of the T–N (non-solvated) polymorph of torasemide, C16H20N4O3S, a diuretic drug used in the treatment of hypertension, has been redetermined at low temperature ...
Massimo Di Vaira   +3 more
doaj   +2 more sources

Determination of torasemide in human plasma and its bioequivalence study by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry

open access: goldJournal of Pharmaceutical Analysis, 2016
A sensitive and selective method using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (HPLC–ESI–MS) to determine the concentration of torasemide in human plasma samples was developed and validated ...
Lin Zhang   +3 more
doaj   +2 more sources

Subcutaneous Furosemide Therapy for Chronic Management of Refractory Congestive Heart Failure in Dogs and Cats [PDF]

open access: yesAnimals
Reduced efficacy of oral diuretics in the treatment of congestive heart failure (CHF) can be secondary to reduced enteral drug absorption. The aim of this study was to determine the efficacy of subcutaneous (SC) furosemide administration to control the ...
Sergio F. Lombardo   +2 more
doaj   +2 more sources

Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma [PDF]

open access: yesFrontiers in Pharmacology
High-dose methotrexate (HDMTX) is the cornerstone of the treatment for primary central nervous system lymphoma (PCNSL). The prevention of drug-induced toxicities is critical.
Wenshu Li   +14 more
doaj   +2 more sources

The experience of successful use of dapagliflozin to manage adverse effects due to uncontrolled and long-term use of torasemide in a patient with type 2 diabetes mellitus with comorbid obesity. A clinical example

open access: yesКлинический разбор в общей медицине
This article provides an example of a smooth and successful withdrawal of long-term and unjustified use of a diuretic (torasemide) in patients with type 2 diabetes mellitus with comorbid obesity by prescribing sodium-glucose cotransporter type 2 ...
Vitaly V. Gorban, Ivan A. Gerasimenko
doaj   +2 more sources

Optimization and Validation of a Sensitive HPLC–PDA Method for Simultaneous Determination of Torasemide and Spironolactone in Human Plasma using Central Composite Design

open access: diamondActa Chimica Slovenica, 2015
A sensitive, accurate, precise and rapid HPLC-PDA method was developed and validated for the simultaneous determination of torasemide and spironolactone in human plasma using Design of experiments. Central composite design was used to optimize the method
Venkatesan Subramanian   +2 more
doaj   +3 more sources

Torasemide-induced IgA vasculitis in a patient with heart failure [PDF]

open access: bronzeJournal of Geriatric Cardiology, 2023
Lin-Yu YU   +4 more
openalex   +2 more sources

Loop Diuretic Therapy in Severe Aortic Stenosis: Marker of Organ Congestion, Unfavorable Hemodynamics, and Increased Post-Valve Replacement Mortality. [PDF]

open access: yesClin Cardiol
Aortic stenosis patients on loop diuretic therapy have more evidence of congestion, higher filling pressures, and lower cardiac index, worse functional status several months after aortic valve replacement, and higher long‐term mortality after valve replacement than those without.
Maeder MT   +9 more
europepmc   +2 more sources

TORASEMIDE IN PREVENTION OF MITRAL REGURGITATION AND CHRONIC HEART FAILURE WORSENING IN POSTINFARCTION PERIOD

open access: greenРоссийский кардиологический журнал, 2018
In the review, the results of scientific research provided, conducted with aim to study influence of ischemic mitral regurgitation (IMR) on the development and progressionof chronic heart failure (CHF).
A. A. Abdullaev   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy